Post prostatectomy outcomes of patients with high-risk prostate cancer treated with neoadjuvant androgen blockade-Reference-Cited by-同舟云学术

Post prostatectomy outcomes of patients with high-risk prostate cancer treated with neoadjuvant androgen blockade

Published:2017-12-20 Issue:3 Volume:21 Page:364-372
ISSN:1365-7852
Container-title:Prostate Cancer and Prostatic Diseases
language:en
Short-container-title:Prostate Cancer Prostatic Dis

Author:

McKay Rana R.,Montgomery Bruce,Xie Wanling,Zhang Zhenwei,Bubley Glenn J.,Lin David W.,Preston Mark A.,Trinh Quoc-Dien,Chang Peter,Wagner Andrew A.,Mostaghel Elahe A.,Kantoff Philip W.,Nelson Peter S.,Kibel Adam S.,Taplin Mary-Ellen

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Urology,Oncology

Link

http://www.nature.com/articles/s41391-017-0009-6.pdf

Reference35 articles.

1. Eggener SE, Scardino PT, Walsh PC, Han M, Partin AW, Trock BJ, et al. Predicting 15-year prostate cancer specific mortality after radical prostatectomy. J Urol. 2011;185:869–75.

2. Brockman JA, Alanee S, Vickers AJ, Scardino PT, Wood DP, Kibel AS, et al. Nomogram predicting prostate cancer-specific mortality for men with biochemical recurrence after radical prostatectomy. Eur Urol. 2015;67:1160–7.

3. Mauri D, Pavlidis N, Ioannidis JP. Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis. J Natl Cancer Inst. 2005;97:188–94.

4. Meeks JJ, Bellmunt J, Bochner BH, Clarke NW, Daneshmand S, Galsky MD, et al. A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer. Eur Urol. 2012;62:523–33.

5. Advanced Bladder Cancer Meta-analysis C. Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis. Lancet. 2003;361:1927–34.

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of risk factors for persistent PSA after radical prostatectomy: results from a high-volume center in Southeast China;BMC Urology;2024-08-29

2. Treatment and Staging Intensification Strategies Associated with Radical Prostatectomy for High-Risk Prostate Cancer: Efficacy Evaluation and Exploration of Novel Approaches;Cancers;2024-07-05

3. A Prospective Randomized Trial of Neoadjuvant Chemohormonal Therapy vs Hormonal Therapy in Locally Advanced Prostate Cancer Treated by Radical Prostatectomy;Journal of Urology;2024-05

4. Localized high-risk prostate cancer harbors an androgen receptor low subpopulation susceptible to HER2 inhibition;2024-02-11

5. Postradical prostatectomy prostate‐specific antigen outcomes after 6 versus 18 months of perioperative androgen‐deprivation therapy in men with localized, unfavorable intermediate‐risk or high‐risk prostate cancer: Results of part 2 of a randomized phase 2 trial;Cancer;2024-01